LIDDS (Local Intelligent Drug Delivery System) develops pharmaceutical products based on a patented and clinically tested drug delivery technology. The properties of LIDDS drug delivery technology means that the release rate can be modified and adapted according to clinical needs, it is injectable in many different tissues and is well tolerated, it disappears completely (dissolved) by hand and is also visible with ultrasound injection. This allows for increased precision in the location adjacent to diseased tissue, eg, tumor tissue with a subsequently controlled, sustained release of well established and accepted substances. Based on the positive results and experience Liproca® Depot, the technology platform that could also apply to many other drugs, primarily for the treatment of other types of localized tumors.
- Patent Overview